IBT
TPTX
International Biotechnology Trust’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-14,093
| Closed | -$8.68M | – | 84 |
|
|
2022
Q1 | $8.68M | Sell |
14,093
-47,648
| -77% | -$29.3M | 1.96% | 20 |
|
|
2021
Q4 | $2.95M | Sell |
61,741
-77,000
| -55% | -$3.67M | 0.66% | 36 |
|
|
2021
Q3 | $9.22M | Buy |
138,741
+17,200
| +14% | +$1.14M | 2.22% | 15 |
|
|
2021
Q2 | $9.48M | Buy |
121,541
+40,000
| +49% | +$3.12M | 2.5% | 14 |
|
|
2021
Q1 | $7.71M | Sell |
81,541
-32,000
| -28% | -$3.03M | 2.04% | 18 |
|
|
2020
Q4 | $13.8M | Buy |
113,541
+78,541
| +224% | +$9.56M | 3.77% | 12 |
|
|
2020
Q3 | $3.05M | Hold |
35,000
| – | – | 0.98% | 24 |
|
|
2020
Q2 | $2.24M | Hold |
35,000
| – | – | 0.74% | 27 |
|
|
2020
Q1 | $1.54M | Hold |
35,000
| – | – | 0.7% | 27 |
|
|
2019
Q4 | $2.18M | Buy |
+35,000
| New | +$2.18M | 0.79% | 32 |
|